Smith Group Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Smith Group Asset Management's GILD Position: Q1 2022 in Review
Smith Group Asset Management held its Gilead Sciences (GILD) position steady in Q1 2022 at 120 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #270.
Smith Group Asset Management first reported a position in GILD in Q1 2014 and has held it in 17 quarters since. The position peaked at $98.4M in Q4 2015. 1,601 funds tracked by Wall St. Rank hold GILD as of Q1 2022.
- Smith Group Asset Management held 120 shares of Gilead Sciences worth $7K as of Q1 2022.
- Smith Group Asset Management left its Gilead Sciences share count unchanged in Q1 2022.
- Gilead Sciences made up ﹤0.01% of Smith Group Asset Management's portfolio in Q1 2022, its #270 holding.
- Smith Group Asset Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 17 quarters since.
- Smith Group Asset Management's Gilead Sciences position peaked at $98.4M in Q4 2015.
- 1,601 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.
Based on Smith Group Asset Management's 13F filing for Q1 2022, filed 5 May 2022.